These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25258034)

  • 21. Cost of illness of Crohn's disease.
    Bodger K
    Pharmacoeconomics; 2002; 20(10):639-52. PubMed ID: 12162753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
    Holko P; Kawalec P; Mossakowska M; Pilc A
    PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of illness of Crohn's disease in Spain.
    Juan J; Estiarte R; Colomé E; Artés M; Jiménez FJ; Alonso J
    Dig Liver Dis; 2003 Dec; 35(12):853-61. PubMed ID: 14703880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe.
    Peña-Longobardo LM; Aranda-Reneo I; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano E; López-Bastida J
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32764338
    [No Abstract]   [Full Text] [Related]  

  • 25. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
    Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
    Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation.
    Gater A; Kitchen H; Heron L; Pollard C; Håkan-Bloch J; Højbjerre L; Hansen BB; Strandberg-Larsen M
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):643-56. PubMed ID: 25985850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.
    Chevreul K; Gandré C; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():43-52. PubMed ID: 27072054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.
    Boschetti G; Nancey S; Daniel F; Pariente B; Lerebours E; Duclos B; Bourreille A; Cadiot G; Fumery M; Moreau J; Marteau P; Bouhnik Y; Louis E; Flourié B;
    Inflamm Bowel Dis; 2016 Dec; 22(12):2924-2932. PubMed ID: 27846194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
    Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
    Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resource use and societal costs for Crohn's disease in Sweden.
    Mesterton J; Jönsson L; Almer SH; Befrits R; Friis-Liby I; Lindgren S
    Inflamm Bowel Dis; 2009 Dec; 15(12):1882-90. PubMed ID: 19408336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.
    Gunnarsson C; Chen J; Rizzo JA; Ladapo JA; Lofland JH
    Dig Dis Sci; 2012 Dec; 57(12):3080-91. PubMed ID: 22790905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America.
    Takizawa C; Thompson PL; van Walsem A; Faure C; Maier WC
    J Alzheimers Dis; 2015; 43(4):1271-84. PubMed ID: 25159675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review.
    McDonald M; Patel DA; Keith MS; Snedecor SJ
    Ocul Surf; 2016 Apr; 14(2):144-67. PubMed ID: 26733111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review.
    Franklin M; Pollard D; Sah J; Rayner A; Sun Y; Dube F; Sutton A; Qin L
    Adv Ther; 2024 Jul; 41(7):2700-2722. PubMed ID: 38833143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
    BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States.
    Kahn SA; Lin CW; Ozbay B; Wang A; Chao J; Skup M
    Inflamm Bowel Dis; 2017 Dec; 23(12):2089-2096. PubMed ID: 28961604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
    Schreiber-Katz O; Klug C; Thiele S; Schorling E; Zowe J; Reilich P; Nagels KH; Walter MC
    Orphanet J Rare Dis; 2014 Dec; 9():210. PubMed ID: 25519771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
    Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
    Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.